Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.
スポンサーリンク
概要
- 論文の詳細を見る
Recent studies have shown that not only plasma B-type natriuretic peptide (BNP)-32, but also plasma proBNP-108 is increased in heart failure (HF), and that the current BNP-32 assay kit crossreacts with proBNP-108. It also was shown that both BNP-32 and proBNP-108 were higher in HF than in normal. The proBNP-108/total BNP (BNP-32 + proBNP-108) ratio was widely distributed and patients with HF with ventricular overload had higher proBNP-108/total BNP ratio than HF patients with atrial overload. Consistent with this finding, proBNP-108 was the major molecular form in ventricular tissue, and BNP-32 was the major molecular form in atrial tissue. In addition, proBNP-108 was the major molecular form of BNP in pericardial fluid. The proBNP-108/total BNP ratio increased with deterioration of HF and decreased with improvement of HF. Thus, not only BNP-32, but also proBNP-108 is increased in HF and the proBNP-108/total BNP ratio also rises in association with pathophysiological conditions such as ventricular overload. A new hypothesis that O-glycosylation at Thr71 in a region close to the cleavage site impairs proBNP-108 processing was proposed. In the future, the precise mechanism of increased proBNP-108 in HF should be elucidated.
論文 | ランダム
- B-4 静翼損傷傾向管理支援システムの開発(システム・運用,一般講演)
- B-7 ガスタービン高温部品の保守計画作成支援システムの開発(高温材料,一般講演)
- 移転価格税制論の源流 : 国際連盟報告書に基づいて
- 独立企業の原則 vs.ユニタリータックス : Carrollの報告に即して
- 納税主体としての企業 : 租税条約におけるエンタープライズの定義をめぐって